Kara L. Mungovan
Lawyers
![](/sites/default/files/styles/teaser_headshot/public/lawyer-images/33486_kmungov_0.jpg?itok=pN9WFi24)
Filters
RAPT Therapeutics $75 million follow-on offering
The shares are listed on the Nasdaq Global Market
Privia Health $135 million secondary offering
We advised Privia on its debut shelf takedown offering
KOITO $100 million investment in Cepton
We are advising KOITO on its investment in convertible preferred stock
One Manhattan Square $217 million mortgage loan
We advised Extell on the refinancing
Roivant Sciences $150 million equity offering
We advised the company on its debut SEC-registered primary and secondary offering
Walgreens $2.25 billion Summit Health-CityMD acquisition financing
We are advising the lender in connection with the facilities
Verisk $3.1 billion sale of Wood Mackenzie to Veritas Capital
We are advising Verisk on the transaction
Canopy Growth credit agreement amendment
We advised certain lenders under the term loan credit facility
ADT $1.2 billion cash tender offer for stock
The company’s shares are traded on the NYSE
Billtrust $1.7 billion acquisition by EQT Private Equity
We are advising Billtrust on the transaction